AI developers who train large language models on copyrighted code just cleared a significant legal hurdle. On September 16, 2026, the 9th Circuit affirmed dismissal of the plaintiffs’ claim in Doe v. GitHub, Inc. under Section 1202(b) of the Digital
If you do use the blog for research or database purposes, and of course for practice purposes, citation would be appreciated, to the blog as a whole and /or to specific blog posts. Many have suggested I should turn the
David Kluft asks: “Can I be adverse to a company that was spun-off from another corporate client?”
Film Encryption and Watermarking for Unauthorized Release Protection by Beth B. Moore
Film Encryption and Watermarking for Unauthorized Release Protection
Your film becomes vulnerable when a copy leaves a controlled environment. A festival screener, post-production transfer, sales-agent link, dubbing file,
The Delhi High Court today raised concerns over Instagram’s ‘Remix’ feature, observing that it could potentially be misused to manipulate and reproduce original content, facilitating copyright infringement.
Justice Anup Jairam Bhambhani made the observations while hearing a suit filed by
The interplay between trademark infringement proceedings and non-use cancellation proceedings under Sections 47 and 124 of the Trade Marks Act, 1999 raises a deceptively simple question: can a Section 47 proceeding trigger a stay of an infringement suit? With the
Welcome back to another week of Bells & Whistles.
As always, we’ve rounded up a mix of developments, opportunities, and thoughtful reads from across the IP world along with a Bell of the Week that’s well worth revisiting.
Bell of
Participant eager to discuss StreamzFrom 25 to 27 November 2026, ERA’s Annual Conference on European Copyright Law returns for three online morning sessions (CET), bringing together practitioners, academics, stakeholders and EU experts to discuss what has been happening and what
In The Receivership Estate of AudienceScience Inc. v. Google LLC, the Federal Circuit affirmed a district court’s grant of judgment on the pleadings that patents covering targeted advertisement are ineligible under 35 U.S.C. § 101 and affirmed dismissal without leave
On September 9, 2026, the U.S. Patent and Trademark Office issued a Notice of Decisions on Institution granting institution in four inter partes review proceedings challenging Janssen Biotech, Inc.’s golimumab method-of-treatment patents: IPR2026-00256, IPR2026-00257, IPR2026-00258, and IPR2026-00259. The notice states,
